Incidence of diabetic retinopathy did not differ between the orforglipron and placebo groups, and no hepatic safety signals were observed in the trial
Your healthcare team can review your injection technique, suggest alternative sites, or investigate whether the reaction represents a true medication allergy requiring treatment adjustment
The body compensates, and weight loss stalls
I have been on it for 4 years now, and it has changed my life
Additionally, its clinically shown to double GLP-1 levels naturally and curb cravings and appetite in just one use (yes, one use!)
However, up to 63% of retatrutide-treated participants lost 15% of body weight in lesser time, which could lead to T2D remission